Phase 2 Platelet Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder
Familial Platelet DisorderHematopoietic
M.D. Anderson Cancer Center6 enrolled1 locationNCT06261060
Recruiting
Phase 2
Delayed Cold-Stored Platelets -PLTS-1
BleedingCardiac SurgeryCardiopulmonary Bypass+1 more
University Health Network, Toronto150 enrolled2 locationsNCT06147531
Recruiting
Phase 1Phase 2
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
Platelet Transfusion Refractoriness
Keymed Biosciences Co.Ltd110 enrolled1 locationNCT06792019
Recruiting
Phase 2
Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO
Cardiogenic ShockExtracorporeal Membrane Oxygenation ComplicationPlatelet Dysfunction
IRCCS San Raffaele50 enrolled1 locationNCT06792643
Recruiting
Phase 2
Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients Undergoing UCBT
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital34 enrolled1 locationNCT06693791
Recruiting
Phase 2
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
Severe Aplastic AnemiaPlatelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China20 enrolled1 locationNCT06254560
Recruiting
Phase 2
effect of alpha lipoic acid on cardiac autonomic function and platelet reactivity in type I diabetes
cardiovascular autonomic neuropathy in type I diabetesincreased platelet reactivity in Type I diabetes
Catholic University60 enrolled1 locationACTRN12610000291088